News
Public · Published
Scotts Miracle-Gro FY2026 Sales Rise 1%; Adjusted EPS Reaches $4.48
Scotts Miracle-Gro reported fiscal 2026 sales of $3.29 billion, up 1% year over year, and adjusted diluted earnings per share of $4.48, up 18%. Free cash flow was $278.4 million. It expects fiscal 2027 sales growth of 2% to 4% and adjusted earnings per share of $4.70 to $4.90.
Published:
Updated:
What happened
Scotts Miracle-Gro reported fiscal 2026 sales of $3.29 billion, up 1% year over year, and adjusted diluted earnings per share of $4.48, up 18%. Free cash flow was $278.4 million. It expects fiscal 2027 sales growth of 2% to 4% and adjusted earnings per share of $4.70 to $4.90.
Confirmed
Global impact / market context
The combination of modest sales growth and higher adjusted earnings per share suggests improved profitability despite limited revenue expansion. If the company meets its fiscal 2027 outlook, higher sales and earnings could support cash generation, while weaker results could constrain available cash and the ability to fund business needs.
Analyst inference
The gap between lower net income and higher adjusted earnings per share makes reported profit quality relevant to investors. If underlying sales growth continues, it could support revenue, while continued margin gains could help offset costs; weaker demand or costs could pressure profits.
Analyst inference
What to watch
- Compare fiscal 2027 sales and adjusted earnings per share with the company’s stated ranges of 2% to 4% growth and $4.70 to $4.90, respectively. Confirmed
- Watch whether gross margin gains continue; gross margin is the share of sales left after direct product costs, and it can influence profit even when sales growth is modest. Analyst inference
- Track whether free cash flow remains sufficient to support company needs, since the reported $278.4 million provides cash after operating costs and investment spending. Analyst inference
Evidence
- Original source link unavailable